Home LiteratureArticle Details
PMID: 19870993 Published · ppublish English Journal Article

A DOG TEST FOR MEASURING THE IMMUNIZING POTENCY OF ANTIRABIES VACCINES.

The Journal of experimental medicine ·Vol. 71 ·No. 5 ·1940-04-30 ·Pages 719-30

Webster LT, Casals J

Abstract

1. A quantitative method is described for testing the immunizing potency of antirabies vaccines in dogs. 2. Phenolized, single-injection, canine vaccines from seven manufacturers, when administered to dogs according to directions, failed to protect them against the least measurable amount of test virus fatal to 50 per cent or more of controls. Chloroformized vaccines from two of three manufacturers, under the same conditions, gave equivocal or suggestive results. 3. Commercial chloroformized vaccines in 10 cc. doses, injected intraperitoneally rather than subcutaneously into dogs, conferred a significant degree of immunity but proved temporarily irritative to the peritoneum. 4. These results of canine vaccines in dogs parallel closely those already reported in mice.

Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Webster L T
Laboratories of The Rockefeller Institute for Medical Research.
Casals J
References (2)
2 references, click to expand
  1. Experiments on Antirabic Vaccination With Tissue Culture Virus.
    Am J Public Health Nations Health. 1938 Jan;28(1):44-6 PMID: 18014765
  2. A MOUSE TEST FOR MEASURING THE IMMUNIZING POTENCY OF ANTIRABIES VACCINES.
    J Exp Med. 1939 Jun 30;70(1):87-106 PMID: 19870893
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1940-04-30
Pages
719-30
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2135099
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com